Skip to main content
logo
Evogene Ltd. (TLV:EVGN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
264.20
+7.90 (3.08%)
At close: Mar 13, 2026

Evogene Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.49-16.49-23.88-26.64-27.79
Depreciation & Amortization
1.142.52.612.582.23
Other Amortization
1.320.47---
Loss (Gain) From Sale of Assets
-0.210.52-0.03-0.12
Asset Writedown & Restructuring Costs
0.25----
Loss (Gain) on Equity Investments
0.040.04---
Stock-Based Compensation
0.651.81.881.192.61
Other Operating Activities
-4.85-5.24-1.76-0.04-3.54
Change in Accounts Receivable
0.67-0.73-0.01-0.07-0.06
Change in Inventory
-1.02-1.740.49-0.47-0.09
Change in Accounts Payable
-0.26-0.60.74-0.470.63
Change in Unearned Revenue
-0.36-0.56-0.29-0.150.13
Change in Other Net Operating Assets
-0.280.32-1.430.491.05
Operating Cash Flow
-13.5-19.7-21.58-23.68-24.72
Capital Expenditures
-0.14-0.63-0.79-1.17-0.85
Sale of Property, Plant & Equipment
0.080.060.03--
Investment in Securities
-010.19-3.7814.45-19.72
Other Investing Activities
17.8----
Investing Cash Flow
17.749.62-4.5413.27-20.57
Long-Term Debt Repaid
-0.53-0.9-0.84-0.8-0.58
Net Debt Issued (Repaid)
-0.53-0.9-0.84-0.8-0.58
Issuance of Common Stock
4.285.628.450.0330.07
Other Financing Activities
-10.36-0.0710.5410.120.79
Financing Cash Flow
-6.64.6618.159.3430.28
Foreign Exchange Rate Adjustments
0.02-0.05-0.25-2.281.1
Net Cash Flow
-2.35-5.47-8.21-3.35-13.9
Free Cash Flow
-13.64-20.33-22.36-24.85-25.56
Free Cash Flow Margin
-353.93%-238.82%-396.49%-1483.52%-2748.71%
Free Cash Flow Per Share
-1.73-3.57-4.87-6.00-6.32
Cash Interest Paid
-0.070.120.170.32
Cash Income Tax Paid
-0.010.030.040.01
Levered Free Cash Flow
-19.4-0.78-12.6-14.89-17.97
Unlevered Free Cash Flow
-18.21-0.74-12.52-14.78-17.77
Change in Working Capital
-1.25-3.31-0.4-0.771.66
Source: S&P Global Market Intelligence. Standard template. Financial Sources.